End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
407.8 EUR | +1.19% |
|
+0.74% | +10.14% |
Jun. 07 | Russian court orders $56 mln Landesbank Baden-Wuerttemberg asset seizure | RE |
May. 30 | ESAB to Acquire Linde Industries Private in Bangladesh for Undisclosed Sum | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 31.3 and 27.75 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.14% | 210B | - | ||
+24.63% | 12.95B | B | ||
+64.32% | 9.46B | C+ | ||
-15.78% | 3.34B | D+ | ||
+11.58% | 3.12B | C- | ||
+13.85% | 3.07B | C+ | ||
+10.72% | 2.29B | - | ||
-9.91% | 2.24B | - | ||
+3.96% | 1.66B | - | - | |
-22.42% | 1.24B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LIN Stock
- LIN Stock
- Ratings Linde plc